Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 2020

View Archived Issues

Innovent initiates phase I/II studies of IBI-318

Blood cells. Lots of them

FDA accepts IND application for phase Ia study of PRA-023

First participant dosed in phase I study of TBAJ-587

Sichuan Haisco Pharmaceutical patents CRBN-comprising PROTACs

Galapagos discloses new SIK inhibitors

Shanghai Zhimeng Biopharma presents new KCNQ2 activators

KEAP1/NRF2 interaction inhibitors presented by Ube Industries

Positive final data presented from COMBAT/KEYNOTE-202 triple combination study in PDAC

GenScript discloses new CD47 and PD-L1-targeting proteins

Evaluation of the modafinil analogue (S,S)-CE-158 in neurochemical and behavioral studies in rats

Cerecor initiates dosing in phase Ib study of CERC-007 in relapsed/refractory multiple myeloma

NP + GPC DNA vaccine candidate protects cynomolgus macaques from Crimean-Congo hemorrhagic fever

Topline data from phase II study of vocacapsaicin in total knee arthroplasty surgery

Researchers develop a mitometin-testing murine model of ALS

First subjects dosed in phase I study of PN-235

Abpro initiates phase II/III registrational studies of ABP-300 as treatment of COVID-19

FDA places partial clinical hold on odronextamab lymphoma trials

Phase I data presented for cannabidivarin for treating epilepsy in patients with Rett syndrome

Through mTOR, ketamine affects protein translation hub

FDA approves Margenza for pretreated metastatic HER2-positive breast cancer

New phase III trial evaluates siltuximab for COVID-19 or viral-associated ARDS

Molecular Partners advances pipeline

Heat Biologics completes ZVX-60 gp96-based COVID-19 vaccine cell line

Interim phase II data for darolutamide demonstrate efficacy in advanced AR-positive TNBC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...